VS
BMO SPDR Health Care Select Sector Index ETF (ZXLV) and Hamilton Healthcare Yield Maximizer ETF (LMAX) offer distinct profiles for Canadian ETF investors. A direct comparison shows that ZXLV focuses its top 3 sector exposures on Healthcare and Consumer Non-Cyclicals, while LMAX leans towards Healthcare and Consumer Non-Cyclicals. When evaluating costs, ZXLV features a management fee (MER) of 0.21%, compared to 0.65% for LMAX. Performance-wise, ZXLV has returned 9.03% year-to-date with +$24 M in net flows, whereas LMAX is at 4.77% with +$71 M. Use the comparison tool below to benchmark these funds across top 10 holdings, yield, sector weights and historical returns.
NAV Performance and Flows
Key Data
Compare
ZXLV
LMAX
| AuM | $39.97 M | $226.66 M |
| Management Fees | 0.21% | 0.65% |
| Exp. ratio | 0.21% | 0.80% |
| Tracking Difference | - | - |
Historical performance and flows
As of September 9, 2026
| 1M | 3M | YTD | 1Y | 3Y | ||
|---|---|---|---|---|---|---|
| Perf. | ZXLV | -2.03% | +7.09% | +9.03% | +21.47% | - |
LMAX | -2.38% | +5.40% | +4.77% | +13.67% | - | |
| Flows | ZXLV | -$5 M | +$17 M | +$24 M | +$35 M | - |
LMAX | +$5 M | +$16 M | +$71 M | +$85 M | - |
ZXLV vs LMAX exposure
Countries
ZXLV
USA
97.53%
LMAX
USA
95.96%
Sectors
ZXLV
Healthcare
97.51%
LMAX
Healthcare
94.79%
As of September 9, 2026
Top 10 Holdings
ZXLV
Eli Lilly & Co.
15.48%
Johnson & Johnson
10.51%
AbbVie, Inc.
7.55%
UnitedHealth Group, Inc.
6.41%
Merck & Co., Inc.
5.48%
Thermo Fisher Scientific, Inc.
3.64%
Amgen, Inc.
3.54%
Abbott Laboratories
3.14%
Gilead Sciences, Inc.
2.75%
Pfizer Inc.
2.43%
LMAX
AbbVie, Inc.
5.92%
CVS Health Corp.
5.89%
UnitedHealth Group, Inc.
5.86%
Eli Lilly & Co.
5.77%
Thermo Fisher Scientific, Inc.
5.75%
Bristol Myers Squibb Co.
5.50%
Amgen, Inc.
5.25%
Johnson & Johnson
5.21%
Merck & Co., Inc.
5.20%
Abbott Laboratories
5.09%
Diversification
ZXLV
Total weight of top 10 holdings out of 59 total
60.94%
LMAX
Total weight of top 10 holdings out of 20 total
55.45%
Characteristics
Compare
ZXLV
LMAX
| Provider | BMO | Hamilton ETFs |
| Management | Passively managed | Actively managed |
| Benchmark | S&P Health Care Select Sector Total Return Index - USD | - |
| Replication Method | ||
| Asset Class | Equity | Equity |
| Dividend Policy | Distributing | Distributing |
| Trailing 12m distribution yield | 0.46% | 12.50% |
| Meets ESG criteria | No | No |
| Inception Date | February 2, 2025 | February 6, 2024 |
Frequently asked questions about ZXLV and LMAX
Which ETF has performed better year to date: ZXLV or LMAX?
As of September 9, 2026, ZXLV has returned 9.03% year to date, while LMAX has returned 4.77%. ZXLV is ahead on YTD performance.
Which ETF is larger by assets under management: ZXLV or LMAX?
As of September 9, 2026, ZXLV manages $39.97 M in assets, while LMAX manages $226.66 M. LMAX is the larger fund by AUM.
How are ZXLV and LMAX managed?
ZXLV is passively managed by BMO. It tracks the S&P Health Care Select Sector Total Return Index - USD benchmark. LMAX is actively managed by Hamilton ETFs. It does not track an index.
What sectors do ZXLV and LMAX emphasize?
ZXLV is most exposed to Healthcare and Consumer Non-Cyclicals. LMAX is most exposed to Healthcare and Consumer Non-Cyclicals.
Which ETF is attracting more investor flows: ZXLV or LMAX?
Year to date, ZXLV has seen +$23.63 M in net flows, compared with +$71.11 M for LMAX. LMAX has attracted more net investor money so far.
How do the fees of ZXLV and LMAX compare?
ZXLV has an expense ratio of 0.21%, while LMAX has an expense ratio of 0.80%.
What are the top holdings of ZXLV and LMAX?
ZXLV's largest holdings include Eli Lilly & Co., Johnson & Johnson, and AbbVie, Inc.. LMAX's top holdings include AbbVie, Inc., CVS Health Corp., and UnitedHealth Group, Inc..
Which ETF is more diversified: ZXLV or LMAX?
ZXLV holds 59 securities, while LMAX holds 20. On holdings count, ZXLV is the more diversified portfolio.
Recent articles about ZXLV and LMAX
The ETF Market Canada is brought to you by Cboe in partnership with Trackinsight SA who is providing all the data, analysis and editorial content on this site. Unless explicitly stated as such, any information that you receive is not real-time.
All content on the ETF Market Canada is for your general information use only, Cboe is not responsible for any use of content by you outside this scope. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by Cboe and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
All content on the ETF Market Canada is for your general information use only, Cboe is not responsible for any use of content by you outside this scope. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by Cboe and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.